Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Changchun Huayang Pharmaceutical Co., Ltd. is a comprehensive pharmaceutical enterprise based in the High-tech Industrial Development Zone of Changchun, Jilin Province, China. Established in 1993, the company specializes in the research, development, and large-scale production of both chemical drugs and Traditional Chinese Medicine (TCM) formulations. Its commercial portfolio includes widely recognized products such as Metformin Hydrochloride for metabolic disorders and Compound Liquorice Tablets for respiratory relief. The company operates modern, GMP-certified manufacturing facilities capable of producing various dosage forms, including tablets, capsules, and granules. Changchun Huayang Pharmaceutical primarily serves the domestic Chinese market, focusing on providing essential and high-quality medications to healthcare providers and patients.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Changchun Huayang Pharmaceutical.